Real-World Evidence Research
Specialist end-to-end consultation to strengthen evidence strategies and improve research outcomes.
Regulatory-grade data for more impactful research
TriNetX data is research-grade and research-ready. No matter the analyses you conduct with our data, our experts are on hand to guide you from concept to publication.
From exploratory research to regulatory and safety studies, we help you turn our data into impactful evidence, tailored to your specific needs.
How can we support your research?
Identify unmet needs, assess disease burden and progression, and make smarter internal decisions with robust R&D studies informed by real-world data.
Demonstrate intervention value, healthcare utilization, and patient journeys through rigorous, data-driven HEOR studies.
Ensure compliance and support regulatory requirements with validated real-world evidence.
Our RWE research services
Explore how we help you design and deliver quality data-driven research.
Develop fit-for-purpose study designs and strategies that produce robust, actionable outcomes.
Create detailed study protocols and statistical analysis plans (SAPs) that align with community standards to ensure quality, integrity, and acceptance.
Deliver rigorous, process-driven studies, including expertly developed reports, manuscripts, and abstracts to share findings with targeted audiences.
Collaborate with our industry and academic experts to drive innovation and address unique scientific questions.
Want to learn more?
Explore our related insights
Big data isn’t always the right data. Learn how to assess whether a dataset is truly fit for your research question, because data fitness is about the right elements for the right cohort, not dataset size or reputation.
EHR data is one of the richest sources for real-world research, but it was never actually designed for it. This video covers the opportunities, the pitfalls, and the mindset needed to get the most out of it.
Misaligned definitions don’t just complicate analysis; they produce misleading results. Learn why harmonized definitions are essential for multi-site RWD studies and what it takes to make them stand up to scientific and regulatory scrutiny.
At ISPOR 2026, we presented posters addressing outcomes in relapsed/refractory DLBCL, and introducing a reproducible method for generating population estimates robust enough to stand up in HTA and regulatory submissions.
Contact TriNetX
Need to reach out? We’re here to help.
"*" indicates required fields
